Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 19Multiple Sclerosis Research StudiesPolyomavirus and related diseasesPeripheral Neuropathies and Disorders

The DOI matches its Crossref record.

Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis

Andreadou, E., Chatzipanagiotou, S., Constantinides, V.C., Rombos, A., Stamboulis, E., Nicolaou, C.·2013·Clinical Neurology and Neurosurgery
DOI 10.1016/j.clineuro.2013.07.026
Open this paper in CoChat — free account

Abstract

Unlabelled Lower prevalence of cerebrospinal fluid oligoclonal IgG bands (IgG-OCBs) has been reported in multiple sclerosis (MS) patients from Southern Europe compared to other western countries. Objectives We aimed to determine the prevalence of CSF OCBs in Greek MS patients and to examine their relation with some selected clinical and demographical features. Methods Included patients fulfilled the 2005 McDonald criteria for definite MS (CDMS) or clinically isolated syndrome (CIS) and had a spinal tap performed between 2006 and 2010. Paired CSF and plasma samples were analyzed using isoelectric focusing followed by IgG-specific immunofixation. A pattern of two or more bands present only in the CSF was defined as positive. OCB status was correlated with age at disease onset, initial symptomatology, relapse rate, disease subtype, disease duration, medication, EDSS score and MSSS. Results Of the 231 included patients (53.2% with CDMS and 48.6% with CIS) 67.5% had OCBs. The prevalence of positive patterns did not differ between CIS and CDMS patients (67.6% vs. 67.5%, respectively). OCB-positive patients were younger than OCB-negative patients (35.2±10.3 vs. 38.7±11.8 years respectively, p=0.022) and had more frequently cervical spinal cord lesions (x2=7.08, p=0.008). No difference was observed between the two subgroups in the other studied disease parameters. Conclusion Despite the lower frequency of positive IgG-OCB patterns in our patients, both subgroups were mostly similar w…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.clineuro.2013.07.026

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Research works printed but not linked: 31

  1. Link, 2006, Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness, Journal of Neuroimmunology, 180, 17, 10.1016/j.jneuroim.2006.07.006 · DOI
  2. Idiman, 2009, The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds, Journal of Neuroimmunology, 212, 121, 10.1016/j.jneuroim.2009.04.014 · DOI
  3. Zeman, 1996, A study of oligoclonal band negative multiple sclerosis, Journal of Neurology, Neurosurgery and Psychiatry, 60, 27, 10.1136/jnnp.60.1.27 · DOI
  4. Sa, 2005, Oligoclonal IgG bands in the CSF of Portuguese patients with MS, Arq Neuropsiquiatr, 63, 375
  5. Joseph, 2009, CSF oligoclonal band status in multiple sclerosis: a case control study of 100 patients, Journal of Neurology, Neurosurgery and Psychiatry, 80, 292, 10.1136/jnnp.2008.150896 · DOI
  6. Nakashima, 2002, A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands, Multiple Sclerosis, 8, 459, 10.1191/1352458502ms831oa · DOI
  7. Imrell, 2006, Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct, Neurology, 67, 1062, 10.1212/01.wnl.0000237343.93389.35 · DOI
  8. Siritho, 2009, The prognostic significance of cerebrospinal fluid in multiple sclerosis, Journal of the Neurological Sciences, 15, 21, 10.1016/j.jns.2008.12.029 · DOI
  9. Polman, 2005, Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria, Annals of Neurology, 58, 840, 10.1002/ana.20703 · DOI · Paper page
  10. Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 · DOI · Paper page
  11. Roburgh, 2005, Multiple sclerosis severity score: using disability and disease duration to rate disease severity, Neurology, 64, 1144, 10.1212/01.WNL.0000156155.19270.F8 · DOI · Paper page
  12. Kikuchi, 2003, HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands, Neurology, 60, 647, 10.1212/01.WNL.0000048202.09147.9E · DOI
  13. Wu, 2008, Characterisation of the spectrum of demyelinating disease in Western Australia, Journal of Neurology, Neurosurgery and Psychiatry, 79, 1022, 10.1136/jnnp.2007.131177 · DOI
  14. Andersson, 1994, Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report, Journal of Neurology, Neurosurgery and Psychiatry, 57, 897, 10.1136/jnnp.57.8.897 · DOI · Paper page
  15. Csako, 2012, Isoelectric focusing in agarose gel for detection of oligoclonal bands in cerebrospinal and other biological fluids, Methods in Molecular Biology, 869, 247, 10.1007/978-1-61779-821-4_20 · DOI
  16. Awad, 2010, Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis, Journal of Neuroimmunology, 219, 1, 10.1016/j.jneuroim.2009.09.002 · DOI
  17. Lundkvist, 2010, Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta, Multiple Sclerosis, 16, 796, 10.1177/1352458510373112 · DOI
  18. Romero-Pinel, 2011, Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort, European Journal of Neurology, 18, 1258, 10.1111/j.1468-1331.2011.03379.x · DOI
  19. Wu, 2010, Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort, Journal of the Neurological Sciences, 288, 63, 10.1016/j.jns.2009.10.005 · DOI
  20. Kouri, 2011, HLA associations with multiple sclerosis in Greece, Journal of the Neurological Sciences, 308, 28, 10.1016/j.jns.2011.06.037 · DOI
  21. Fernández, 2009, HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain), Journal of Neurology, 256, 1977, 10.1007/s00415-009-5223-2 · DOI
  22. Cocco, 2012, HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia, PLoS ONE, 7, e33972, 10.1371/journal.pone.0033972 · DOI
  23. Korn, 2012, Patterns of intrathecal autoreactive antibodies in MS using antigen microarrays, Neurology, 78, 522, 10.1212/WNL.0b013e318247fa26 · DOI
  24. Brecht, 2012, Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis, PLoS ONE, 7, e40431, 10.1371/journal.pone.0040431 · DOI
  25. Masterman, 2000, HLA-DR15 is associated with lower age at onset in multiple sclerosis, Annals of Neurology, 48, 211, 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.0.CO;2-R · DOI
  26. Ramagopalan, 2009, Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis, Journal of Human Genetics, 54, 547, 10.1038/jhg.2009.69 · DOI
  27. Imrell, 2009, T.HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis, Journal of Neuroimmunology, 210, 128, 10.1016/j.jneuroim.2009.03.005 · DOI
  28. Qiu, 2010, Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia, Journal of Clinical Neuroscience, 17, 1009, 10.1016/j.jocn.2009.12.011 · DOI
  29. Greer, 2008, Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis, The Journal of Immunology, 180, 6402, 10.4049/jimmunol.180.9.6402 · DOI
  30. Huttner, 2009, MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns, Journal of Neurology, 256, 1121, 10.1007/s00415-009-5081-y · DOI
  31. Karrenbauer, 2013, Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients, Journal of Neuroimmunology, 254, 170, 10.1016/j.jneuroim.2012.08.011 · DOI

Cited by

See all 19

Metadata

Authors
Andreadou, E., Chatzipanagiotou, S., Constantinides, V. C., Rombos, A., Stamboulis, E., & Nicolaou, C.
Affiliations
Eginition Hospital (GR)
Corresponding author
Andreadou, E.
ORCID
Venue
Clinical Neurology and Neurosurgery
Publisher
Elsevier BV
Published
2013-10
Volume
115
Issue
10
Pages
2094-2098
ISSN
0303-8467 (ISSN-L)
DOI
10.1016/j.clineuro.2013.07.026
OpenAlex
W2104218092
Cited by
19
References
0
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Clinical Neurology and Neurosurgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
  • Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords
multiple sclerosis, clinically isolated syndrome, prevalence, Greek patients, cervical spinal cord injury, age of onset, prognostic value, disease subtypes, Expanded Disability Status Scale
MeSH terms
Adult, Age Factors, Female, Greece, Humans, Immunoglobulin G, Immunoelectrophoresis, Male, Middle Aged, Multiple Sclerosis, Recurrence, Spinal Cord, Prevalence, Age of Onset, Oligoclonal Bands

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis. https://app.cochat.ai/papers/10.1016/j.clineuro.2013.07.026
The paper
Andreadou, E., Chatzipanagiotou, S., Constantinides, V. C., Rombos, A., Stamboulis, E., & Nicolaou, C. (2013). Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis. Clinical Neurology and Neurosurgery. https://doi.org/10.1016/j.clineuro.2013.07.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.